Gefitinib response after acquisition of C797S following first-line osimertinib in EGFR L858R/E709K-mutated non-small cell lung cancer: A case report. // Respiratory Investigation. – URL: https://www.sciencedirect.com/science/article/pii/S2212534526001425?dgcid=rss_sd_all
Gefitinib response after acquisition of C797S following first-line osimertinib in EGFR L858R/E709K-mutated non-small cell lung cancer: A case report. Respiratory Investigation. https://www.sciencedirect.com/science/article/pii/S2212534526001425?dgcid=rss_sd_all
“Gefitinib response after acquisition of C797S following first-line osimertinib in EGFR L858R/E709K-mutated non-small cell lung cancer: A case report.” Respiratory Investigation.
@article{article64310,
title = {Gefitinib response after acquisition of C797S following first-line osimertinib in EGFR L858R/E709K-mutated non-small cell lung cancer: A case report},
journal = {Respiratory Investigation},
url = {https://www.sciencedirect.com/science/article/pii/S2212534526001425?dgcid=rss_sd_all}
}